Status:
COMPLETED
Effects of Personalized Actionable Connected Extensible (PACE) Interventions Among Patients With Chronic Kidney Disease
Lead Sponsor:
National Cheng Kung University
Conditions:
CKD - Chronic Kidney Disease
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
This is a randomized controlled trial study conducted on frail patients with chronic kidney disease(CKD).
Detailed Description
The study will be conducted on 120 frail patients with CKD, who will be divided into 2 groups: Group 1, consisting of 60 frail patients, will receive PACE intervention (based on mobile social network ...
Eligibility Criteria
Inclusion
- Diagnosed with CKD stage 1 to 5
- Participants with pre-frail and frail conditions.
- Having access to a mobile phone and is capable of using mobile social network application (Line)
Exclusion
- Received renal replacement therapy
- Participants achieved TTM stage 5
Key Trial Info
Start Date :
October 19 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2024
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06065501
Start Date
October 19 2023
End Date
September 30 2024
Last Update
June 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cheng Kung University Hospital
Tainan, Taiwan